![Klaus Dugi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Klaus Dugi
Società | Posizione | Inizio | Fine |
---|---|---|---|
AOBiome Therapeutics, Inc.
![]() AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 06/08/2018 | - |
NanoDimension Management Ltd.
![]() NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Consulente / Consigliere | 01/01/2021 | - |
Investitore di Private Equity | 01/01/2021 | - | |
Vandria SA
![]() Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Amministratore Delegato | 01/10/2021 | - |
Storia della carriera di Klaus Dugi
Precedenti posizioni note di Klaus Dugi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ferring Pharmaceuticals BV
![]() Ferring Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals BV develops and manufactures pharmaceutical products. It manufactures pharmaceuticals within the fields of urology, gynecology, gastroenterology, and endocrinology. The company is headquartered in Moscow, Russia. | Corporate Officer/Principal | 01/10/2017 | 31/12/2020 |
Presidente | 01/10/2017 | 31/12/2020 | |
Boehringer Ingelheim Ltd.
![]() Boehringer Ingelheim Ltd. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom. | Investitore di Private Equity | 01/08/2015 | - |
Corporate Officer/Principal | 01/01/2010 | 31/07/2015 | |
Presidente | 01/07/2006 | 31/12/2009 |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Regno Unito | 2 |
Svizzera | 2 |
Posizioni
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
President | 2 |
Settori
Health Technology | 5 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Boehringer Ingelheim Ltd.
![]() Boehringer Ingelheim Ltd. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom. | Health Technology |
AOBiome Therapeutics, Inc.
![]() AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Health Technology |
NanoDimension Management Ltd.
![]() NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Finance |
Vandria SA
![]() Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Health Technology |
Ferring Pharmaceuticals BV
![]() Ferring Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals BV develops and manufactures pharmaceutical products. It manufactures pharmaceuticals within the fields of urology, gynecology, gastroenterology, and endocrinology. The company is headquartered in Moscow, Russia. | Health Technology |
- Borsa valori
- Insiders
- Klaus Dugi
- Esperienza